Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Heart Transplant: early-phase trial registry

7 of 13 indexed Heart Transplant trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 7 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Heart Transplant: 13 US clinical trials tracked, 7 recruiting.

Heart Transplant is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is TransMedics, running 6 of these trials.

Enrollment posture brief

Registry condition heart-transplant

OPEN 7 | RECR 54% | LATE 1 | EARLY 2 | RANK #1315 | SPON 6

Nearest open-share peer: Advanced Renal Cell Carcinoma (54% recruiting · 13 trials)

ACL Injury61.5%Heart Transplant (this)54%Acute Biphenotypic Leukemia46.2%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Heart Transplant

Heart Transplant lists 7 open slots (54% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Heart Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Heart Transplant is recruiting above its size-band peers.

    7 of 13 indexed trials (53.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Heart Transplant research.

    TransMedics accounts for 6 of 13 trials (46.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Heart Transplant enrolment sits around 147 participants.

    Median target enrolment is 147 among the 13 trials that report a genuine target (sentinel values excluded). 6 of those (46.2%) plan for fewer than 100 participants.

  4. Heart Transplant splits between interventional and observational designs.

    9 interventional and 4 observational studies make up this index (69.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 41

Open and recent trials

13 total, page 1 of 1

RECRUITING 100,000 participants

US National OCS Heart Perfusion (OHP) Registry

TransMedics

NCT05915299

RECRUITING NA 655 participants

Enhancing Heart Allograft Function With the OCS Heart System Trial

TransMedics

NCT07145515

RECRUITING NA 516 participants

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

University of California, San Francisco

NCT05933083

RECRUITING Phase 4 200 participants

Randomized Trial of SGLT2i in Heart Transplant Recipients

VA Office of Research and Development

NCT06625073

RECRUITING 90 participants

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Masonic Cancer Center, University of Minnesota

NCT05025774

RECRUITING Phase 2 66 participants

Belatacept in Heart Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06478017

RECRUITING NA 60 participants

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

XVIVO Perfusion

NCT06895070

ACTIVE NOT RECRUITING 276 participants

OCS DCD Heart + CAP Continued Follow-Up

TransMedics

NCT05741723

ACTIVE NOT RECRUITING Phase 2 20 participants

Expanding the Pool in Orthotopic Heart Transplantation

Mary E. Keebler, MD

NCT03222531

COMPLETED NA 180 participants

Donors After Circulatory Death Heart Trial

TransMedics

NCT03831048

COMPLETED 147 participants

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Natera

NCT05309382

COMPLETED NA 75 participants

Heart EXPAND Continued Access Protocol

TransMedics

NCT03835754

COMPLETED NA 75 participants

International EXPAND Heart Pivotal Trial

TransMedics

NCT02323321

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 1

Named interventions

Most-linked intervention names on Heart Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

OCS Heart Device
3 trials
OCS Heart System Device
2 trials
Preservation of Hearts for Transplantation Device
1 trials
Cold Storage Other
1 trials
sofosbuvir/velpatasvir Drug
1 trials
Physical activity Other
1 trials
Static Cold Storage (SCS) Other
1 trials
Mycophenolate Mofetil/Sodium Drug
1 trials

US sites by state

Facility locations filed on Heart Transplant trials. A trial with sites in several states counts in each.

California 11 trials
New York 7 trials
Massachusetts 7 trials
Florida 7 trials
Tennessee 6 trials
North Carolina 6 trials
Minnesota 6 trials
Illinois 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Heart Transplant page

13 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 7 Heart Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • TransMedics sponsors the most Heart Transplant trials on record, review their full trial history before evaluating a specific study. See TransMedics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heart Transplant condition card totals 13 registered trials; most-linked intervention OCS Heart; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.